Dr. Reddy's Laboratories Ltd. ADR (RDY)
NYSE · ADR · CUSIP 256135203
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for RDY and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
256135203
Market Cap
Large Cap
Business: Dr. Reddy's Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through their three businesses, Pharmaceutical Services & Active Ingredients, Global Generics, and Proprietary Products, Dr. Reddy's offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Major therapeutic areas of focus are gastro-intestinal, cardiovascular, diabetology, oncology, pain management and anti-infectives. Dr. Reddy's operates in markets across the globe. Major markets include the United States, Russia and CIS, and India.

Company Contact

CEO
Milan Kalawadia
CFO
Saumen Chakraborty
Headquarters
107 College Road East, Princeton, NJ 08540
Phone
609-375-9900
Fax
609-228-6090
Investor Relations
Ashish Girotra · 609-375-9805 · ashishg@drreddys.com
General Email
kedaru@drreddys.com
SEC EDGAR Filings
View filings » (ownership filings only)